BBVA USA Bancshares’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,046
| Closed | -$540K | – | 535 |
|
|
2020
Q1 | $540K | Buy |
3,046
+1,282
| +73% | +$241K | 0.04% | 309 |
|
|
2019
Q4 | $337K | Buy |
1,764
+133
| +8% | +$24K | 0.02% | 432 |
|
|
2019
Q3 | $274K | Buy |
+1,631
| New | +$266K | 0.02% | 336 |
|
|
2018
Q4 | – | Sell |
-1,217
| Closed | -$232K | – | 543 |
|
|
2018
Q3 | $232K | Sell |
1,217
-262
| -18% | -$48.1K | 0.01% | 502 |
|
|
2018
Q2 | $247K | Sell |
1,479
-933
| -39% | -$150K | 0.02% | 481 |
|
|
2018
Q1 | $406K | Sell |
2,412
-1,673
| -41% | -$281K | 0.03% | 401 |
|
|
2017
Q4 | $668K | Sell |
4,085
-2,187
| -35% | -$392K | 0.04% | 326 |
|
|
2017
Q3 | $1.28M | Sell |
6,272
-1,490
| -19% | -$347K | 0.08% | 224 |
|
|
2017
Q2 | $1.89M | Buy |
7,762
+96
| +1% | +$22.6K | 0.12% | 165 |
|
|
2017
Q1 | $1.83M | Sell |
7,666
-1,640
| -18% | -$382K | 0.12% | 166 |
|
|
2016
Q4 | $1.95M | Sell |
9,306
-986
| -10% | -$204K | 0.14% | 151 |
|
|
2016
Q3 | $2.37M | Sell |
10,292
-1,174
| -10% | -$287K | 0.17% | 128 |
|
|
2016
Q2 | $2.65M | Sell |
11,466
-7,100
| -38% | -$1.64M | 0.2% | 119 |
|
|
2016
Q1 | $4.98M | Sell |
18,566
-5,379
| -22% | -$1.54M | 0.38% | 66 |
|
|
2015
Q4 | $7.48M | Buy |
23,945
+953
| +4% | +$284K | 0.56% | 44 |
|
|
2015
Q3 | $6.25M | Buy |
22,992
+9
| +0% | +$2.77K | 0.49% | 55 |
|
|
2015
Q2 | $6.97M | Sell |
22,983
-349
| -1% | -$104K | 0.39% | 82 |
|
|
2015
Q1 | $6.94M | Buy |
23,332
+1,618
| +7% | +$461K | 0.31% | 110 |
|
|
2014
Q4 | $5.59M | Buy |
21,714
+557
| +3% | +$139K | 0.25% | 124 |
|
|
2014
Q3 | $5.11M | Buy |
21,157
+606
| +3% | +$136K | 0.23% | 130 |
|
|
2014
Q2 | $4.58M | Sell |
20,551
-15
| -0.1% | -$3.11K | 0.2% | 136 |
|
|
2014
Q1 | $4.23M | Buy |
20,566
+219
| +1% | +$43.4K | 0.19% | 144 |
|
|
2013
Q4 | $3.42M | Buy |
20,347
+13,677
| +205% | +$2.14M | 0.15% | 160 |
|
|
2013
Q3 | $960K | Sell |
6,670
-15,352
| -70% | -$2.05M | 0.05% | 256 |
|
|
2013
Q2 | $2.78M | Buy |
+22,022
| New | +$2.49M | 0.14% | 169 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
BBVA USA Bancshares's AGN Position: Q2 2020 in Review
BBVA USA Bancshares sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,046 shares — an estimated $540K sold.
BBVA USA Bancshares first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $7.48M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- BBVA USA Bancshares reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- BBVA USA Bancshares sold 3,046 Allergan plc shares in Q2 2020, an estimated $540K.
- BBVA USA Bancshares first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
- BBVA USA Bancshares's Allergan plc position peaked at $7.48M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on BBVA USA Bancshares's 13F filing for Q2 2020, filed 21 Jul 2020.